NIH Teaming Up With Pharma Giants For New Treatments

The National Institute of Health announced Thursday that three pharmaceutical companies will be granting them access to industry compounds in an attempt to help the Institute spearhead new research into treatments for a wide variety of conditions.

“Americans are eagerly awaiting the next generation of cures and treatments to help them live longer and healthier lives,” Health and Human ServiceTo accelerate our nation’s therapeutic development process, it is essential that we forge strong, innovative, and strategic partnerships across government, academia and industry.”

The companies include AstraZeneca, Lilly and Pfizer and the NIH says that additional companies may eventually sign on. The compounds will be supplied to the NIH’s newly formed Natonal Center for Advancing Translational Sciences.

Tags: , , ,

About TRNS Washington Desk

View all posts by TRNS Washington Desk
TRNS Washington Desk
News updates from on and around Capitol Hill.

LISTEN: The Day Ahead – October 23, 2014

The Day Ahead Logo

Oral arguments begin in a suit against the UN for introducing cholera to Haiti in 2010, a slew of human rights reports and new unemployment data from Spain.

LISTEN: The World in 2:00 – October 22, 2014

The World in 2:00 continents logo

South Sudan’s U.N. ambassador says his country is experiencing a breakdown of social values, and Sweden continues to search for a mysterious underwater vessel.

Obama Phones Canadian Leader Over Deadly Shooting

In a statement released by the White House, President Obama and Prime Minister Stephen Harper will continue to stay in touch as the situation unfolds

WHO: Ebola Health Care Workers Still Seeking Guidance On Use Of Personal Protective Equipment

Plus, The Latest Numbers On The Ebola Virus

State Dept. Won’t Rule Out More Kobani Supply Drops

Norwegian fighter jet assists 2011 Libyan no-fly zone

“This is a small amount of risk,” Deputy State Department Spokesperson Harf said.

Norton: Doubts Raised Over DC Marijuana Legalization Vote

“I’m not sure everyone is prepared for it,” D.C. Congresswoman Eleanor Holmes Norton told TRNS.